The Massachusetts House has passed its version of the 10-year, $1 billion life sciences bill by a vote of 134 to 13. The provisions of the bill, which largely mirror Governor Deval Patrick’s original plans for the biotech initiative, include $250 million for tax credits, $250 million for research grants, and $500 million in bonds for capital projects.
Author: Rebecca Zacks
Rebecca is Xconomy's co-founder. She was previously the managing editor of Physician's First Watch, a daily e-newsletter from the publishers of New England Journal of Medicine. Before helping launch First Watch, she spent a decade covering innovation for Technology Review, Scientific American, and Discover Magazine's TV show. In 2005-2006 she was a Knight Science Journalism Fellow at MIT. Rebecca holds a bachelor's degree in biology from Brown University and a master's in science journalism from Boston University.
View all posts by Rebecca Zacks
